课题基金 / 基金详情

SAM68-induced regulation of cellular metabolism through mTOR mRNA splicing and stabilization

SAM68-induced regulation of cellular metabolism through mTOR mRNA splicing and stabilization
SAM68 通过 mTOR mRNA 剪接和稳定诱导细胞代谢调节
批准号:
RGPIN-2019-06494
负责人:
Huot, MarcÉtienne
金额:
$2.33万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31

项目摘要

项目成果

Huot, MarcÉtienne的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Regulation of cell metabolism is critical for normal cell growth, homoeostasis, integrity and survival. It involves complex sequences of controlled biochemical reactions orchestrated by the mechanistic target of rapamycin (mTOR) signaling pathways. mTOR belongs to the phosphatidylinositol 3 -kinase- related protein family and is known to regulate cell growth, cell proliferation, cell motility, cell survival, protein synthesis and gene transcription. Hence, processes affecting either mTOR expression or its activity will have a major impact on cell metabolism.******In the initial phase of my NSERC research program, we identified SAM68 as a key regulator of mTOR splicing. We found that Sam68 depletion provoked an increase in intron 5 retention, creating a smaller mRNA termed mTORi5. While the exact molecular mechanism remains unknown, our recent investigations showed that SAM68 can interact with U1 snRNP, a core component of the spliceosome, which facilitates 5' splice site recognition. This suggests that interaction between SAM68 and spliceosome component might be essential for mTOR normal splicing and proper splice site recognition. Moreover, while mTORi5 mRNA can be detected, no protein product corresponding to this particular transcript was detected. Still, increased expression of the mTORi5 mRNA variant is associated with a drastic decrease in mTOR full-length protein expression, suggesting that Sam68 has the ability to regulate mTOR expression through a specific alternative splicing checkpoint of mTOR pre-mRNA.******Our hypothesis is that this SAM68--regulated splicing mechanism could be affecting mTOR mRNA stability, thus affecting its activity. Moreover, this mechanism could affect a broader range of mRNA and act as a general mechanism to regulate mRNA splicing and stability in a SAM68-dependent manner. This will be achieved by:******Aim 1: Determining the mechanism by which SAM68 can recruit key spliceosome components and regulates splicing mechanism.******Aim 2: Defining how SAM68 regulates mTOR mRNA stabilization and degradation.******Within this proposed research program, we will define a newly identified SAM68--regulated mechanism affecting alternative splicing and mRNA stability. While most of our research will be initiated using our mTOR model, we will also determine if this SAM68--regulated mechanism affects other mRNA that could act as novel translational safeguard mechanisms involved in cellular integrity.**
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAM68-induced regulation of cellular metabolism through mTOR mRNA splicing and stabilization
  • 批准号:
    RGPIN-2019-06494
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2022
  • 负责人:
    Huot, MarcÉtienne
  • 依托单位:
SAM68-induced regulation of cellular metabolism through mTOR mRNA splicing and stabilization
  • 批准号:
    RGPIN-2019-06494
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2021
  • 负责人:
    Huot, MarcÉtienne
  • 依托单位:
SAM68-induced regulation of cellular metabolism through mTOR mRNA splicing and stabilization
  • 批准号:
    RGPIN-2019-06494
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2020
  • 负责人:
    Huot, MarcÉtienne
  • 依托单位:
国内基金
海外基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
  • 批准号:
    82371144
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    汪雪玲
  • 依托单位:
cGAS-STING激活IFN1反应介导噪声性耳蜗损伤机制研究
  • 批准号:
    82371152
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    冯艳梅
  • 依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
  • 批准号:
    82372203
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李然然
  • 依托单位:
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究